Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic : A comprehensive review. / Caronna, Edoardo; van den Hoek, Thomas C.; Bolay, Hayrunnisa; Garcia-Azorin, David; Gago-Veiga, Ana Beatriz; Valeriani, Massimiliano; Takizawa, Tsubasa; Messlinger, Karl; Shapiro, Robert E.; Goadsby, Peter J.; Ashina, Messoud; Tassorelli, Cristina; Diener, Hans Christoph; Terwindt, Gisela M.; Pozo-Rosich, Patricia.
I: Cephalalgia : an international journal of headache, Bind 43, Nr. 1, 2022, s. 1-18.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic
T2 - A comprehensive review
AU - Caronna, Edoardo
AU - van den Hoek, Thomas C.
AU - Bolay, Hayrunnisa
AU - Garcia-Azorin, David
AU - Gago-Veiga, Ana Beatriz
AU - Valeriani, Massimiliano
AU - Takizawa, Tsubasa
AU - Messlinger, Karl
AU - Shapiro, Robert E.
AU - Goadsby, Peter J.
AU - Ashina, Messoud
AU - Tassorelli, Cristina
AU - Diener, Hans Christoph
AU - Terwindt, Gisela M.
AU - Pozo-Rosich, Patricia
PY - 2022
Y1 - 2022
N2 - OBJECTIVE: The objective is to summarize the knowledge on the epidemiology, pathophysiology and management of secondary headache attributed to SARS-CoV-2 infection and vaccination; as well as to delineate their impact on primary headache disorders. METHODS: This is a narrative review of the literature regarding primary and secondary headache disorders in the setting of COVID-19 pandemic. We conducted a literature search in 2022 on PubMed, with the keywords "COVID 19" or "vaccine" and "headache" to assess the appropriateness of all published articles for their inclusion in the review. RESULTS: Headache is a common and sometimes difficult-to-treat symptom of both the acute and post-acute phase of SARS-CoV-2 infection. Different pathophysiological mechanisms may be involved, with the trigeminovascular system as a plausible target. Specific evidence-based effective therapeutic options are lacking at present. Headache attributed to SARS-CoV-2 vaccinations is also common, its pathophysiology being unclear. People with primary headache disorders experience headache in the acute phase of COVID-19 and after vaccination more commonly than the general population. Pandemic measures, forcing lifestyle changes, seemed to have had a positive impact on migraine, and changes in headache care (telemedicine) have been effectively introduced. CONCLUSIONS: The ongoing COVID-19 pandemic is a global challenge, having an impact on the development of secondary headaches, both in people with or without primary headaches. This has created opportunities to better understand and treat headache and to potentiate strategies to manage patients and ensure care.
AB - OBJECTIVE: The objective is to summarize the knowledge on the epidemiology, pathophysiology and management of secondary headache attributed to SARS-CoV-2 infection and vaccination; as well as to delineate their impact on primary headache disorders. METHODS: This is a narrative review of the literature regarding primary and secondary headache disorders in the setting of COVID-19 pandemic. We conducted a literature search in 2022 on PubMed, with the keywords "COVID 19" or "vaccine" and "headache" to assess the appropriateness of all published articles for their inclusion in the review. RESULTS: Headache is a common and sometimes difficult-to-treat symptom of both the acute and post-acute phase of SARS-CoV-2 infection. Different pathophysiological mechanisms may be involved, with the trigeminovascular system as a plausible target. Specific evidence-based effective therapeutic options are lacking at present. Headache attributed to SARS-CoV-2 vaccinations is also common, its pathophysiology being unclear. People with primary headache disorders experience headache in the acute phase of COVID-19 and after vaccination more commonly than the general population. Pandemic measures, forcing lifestyle changes, seemed to have had a positive impact on migraine, and changes in headache care (telemedicine) have been effectively introduced. CONCLUSIONS: The ongoing COVID-19 pandemic is a global challenge, having an impact on the development of secondary headaches, both in people with or without primary headaches. This has created opportunities to better understand and treat headache and to potentiate strategies to manage patients and ensure care.
KW - COVID-19
KW - Headache
KW - migraine
KW - SARS-CoV-2
KW - telemedicine
KW - vaccine
U2 - 10.1177/03331024221131337
DO - 10.1177/03331024221131337
M3 - Review
C2 - 36606562
AN - SCOPUS:85145645509
VL - 43
SP - 1
EP - 18
JO - Cephalalgia
JF - Cephalalgia
SN - 0800-1952
IS - 1
ER -
ID: 332193445